DK0613459T3 - N-Tritylasparaginsyrederivater til fremstilling af phosphonat NMDA antagonister - Google Patents

N-Tritylasparaginsyrederivater til fremstilling af phosphonat NMDA antagonister

Info

Publication number
DK0613459T3
DK0613459T3 DK92921774.3T DK92921774T DK0613459T3 DK 0613459 T3 DK0613459 T3 DK 0613459T3 DK 92921774 T DK92921774 T DK 92921774T DK 0613459 T3 DK0613459 T3 DK 0613459T3
Authority
DK
Denmark
Prior art keywords
preparation
tritylaspartic
acid derivatives
nmda antagonists
phosphonate
Prior art date
Application number
DK92921774.3T
Other languages
Danish (da)
English (en)
Inventor
Jeffrey P Whitten
Duane E Rudisill
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0613459T3 publication Critical patent/DK0613459T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92921774.3T 1991-11-15 1992-10-13 N-Tritylasparaginsyrederivater til fremstilling af phosphonat NMDA antagonister DK0613459T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79283491A 1991-11-15 1991-11-15

Publications (1)

Publication Number Publication Date
DK0613459T3 true DK0613459T3 (da) 1996-04-01

Family

ID=25158215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92921774.3T DK0613459T3 (da) 1991-11-15 1992-10-13 N-Tritylasparaginsyrederivater til fremstilling af phosphonat NMDA antagonister

Country Status (16)

Country Link
EP (1) EP0613459B1 (hu)
JP (1) JP3168563B2 (hu)
KR (1) KR100241480B1 (hu)
AT (1) ATE134989T1 (hu)
AU (1) AU667845B2 (hu)
CA (1) CA2121835A1 (hu)
DE (1) DE69208888T2 (hu)
DK (1) DK0613459T3 (hu)
ES (1) ES2087555T3 (hu)
FI (1) FI942248A0 (hu)
GR (1) GR3019587T3 (hu)
HU (1) HU214055B (hu)
IL (1) IL103710A (hu)
MX (1) MX9206448A (hu)
NO (1) NO305314B1 (hu)
WO (1) WO1993010075A1 (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025326C (en) * 1989-09-19 2001-04-24 Jeffrey P. Whitten Nmda antagonists

Also Published As

Publication number Publication date
EP0613459A1 (en) 1994-09-07
HU214055B (en) 1997-12-29
IL103710A (en) 1998-02-08
DE69208888T2 (de) 1996-08-01
MX9206448A (es) 1993-05-01
ATE134989T1 (de) 1996-03-15
IL103710A0 (en) 1993-04-04
ES2087555T3 (es) 1996-07-16
HUT70551A (en) 1995-10-30
CA2121835A1 (en) 1993-05-27
NO941820D0 (no) 1994-05-13
DE69208888D1 (de) 1996-04-11
NO941820L (no) 1994-05-13
FI942248A (fi) 1994-05-13
WO1993010075A1 (en) 1993-05-27
KR100241480B1 (ko) 2000-03-02
FI942248A0 (fi) 1994-05-13
GR3019587T3 (en) 1996-07-31
AU2864292A (en) 1993-06-15
HU9401469D0 (en) 1994-08-29
NO305314B1 (no) 1999-05-10
EP0613459B1 (en) 1996-03-06
JP3168563B2 (ja) 2001-05-21
JPH07501523A (ja) 1995-02-16
AU667845B2 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
ES2078257T3 (es) Antagonistas de aminoacidos excitantes.
ES2088011T3 (es) Antagonistas de aminoacidos excitadores.
DE69228330D1 (de) Verfahren zur Herstellung von Waschmittelzusammensetzungen
ATE79637T1 (de) Substituierte alkylamide von teicoplaninverbindungen.
DE69230224D1 (de) Potenzierung von nmda-antagonisten
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
DK0721453T3 (da) Fremgangsmåde til fremstilling af N-methyl-3-(1-methyl-4-piperidinyl)-14-indol-5-ethansulfonamid
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DK0536197T3 (da) Ren, krystallinsk form af rifapentine
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
DK0613459T3 (da) N-Tritylasparaginsyrederivater til fremstilling af phosphonat NMDA antagonister
FI930265A (fi) Antikoagulantpeptider
DE59105908D1 (de) Verfahren zur Herstellung von Bis(hydroxymethyl)phosphinaten.
DE69225254D1 (de) Verfahren zur Herstellung von diarylphosphino Pyridinen
DK113897A (da) Fremgangsmåde til fremstilling af antihypercholesterolæmiske tetrazolforbindelser
DK0717046T3 (da) Fremgangsmåde til fremstilling af phosphonsyrederivater
DE69007362D1 (de) Verfahren zur Herstellung von staubfreiem Natriumdithionit.
DK174591A (da) Fremgangsmaade til fremstilling af sorbinsyre
DK0544171T3 (da) Anvendelse af 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11-oximer til fremstilling af antiretrovirale midler
ES2067417B1 (es) Procedimiento para preparar nuevos derivados en n de (feniletil-beta-ol)-amina.
DK0427160T3 (da) Benzylselenobenzamid af aminopyridiner og picolylaminer
ES2045160T3 (es) Derivados de acilaminometil-3 tetrahidro-5,6,7,8 imidazo-(1,2-a)-piridinas, su preparacion y su aplicacion en terapeutica.
DK0466887T3 (da) Fremgangsmåde til fremstilling af pyrimidintrionderivater
ITMI912138A0 (it) Procedimento per la preparazione di fosfatidi